预混胰岛素联合二甲双胍对新诊断2型糖尿病患者胰岛功能恢复的影响

doi:10.3969/j.issn.1006-6233.2019.01.005

Abstract
Figure/Table
References
Related Citation (0)

Download: PDF (1211 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To analyze the effect of premixed insulin combined with metformin on islet function recovery in newly diagnosed type 2 diabetes mellitus. Methods: 90 patients with newly diagnosed type 2 diabetes who according to simple random number table method were divided into 48 control group and 42 research group. The control group was treated with metformin, and the research group was treated with premixed insulin based on the control group. Then blood glucose compliance time, blood glucose metabolism indicators, islet function, liver and kidney function before and after treatment after 8 weeks and 12 weeks after treatment, and adverse reaction in both group were compared. Results: blood glucose compliance time of research group was higher than that in the control group (7.41±1.02) and (11.78±1.90) days (P<0.05). After 8 weeks and 12 weeks treatment, the blood glucose metabolism indexes in both groups was decreased, and the research group was lower than the control group (P<0.05). The fasting insulin (FINS), insulin resistance index (HOMA-IR) in research group were lower than the control group, while the islet beta cell function (HOMA-β) was higher than the control group, there was a statistically significant difference (P<0.05). liver and kidney function before and after treatment in both group was no statistically significant difference (P>0.05). Both groups had hypoglycemia and gastrointestinal reactions, the incidence of total adverse reactions in both groups was no statistically significant difference (P>0.05). Conclusion: Insulin pretreatment combined with metformin is effective and safe for the new diagnosis of type 2 diabetes, which can effectively control blood glucose and promote the recovery of insulin function.

Key words： Newly diagnosed type 2 diabetes Premixed insulin Metformin Islet function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Jia
	CUI Xuhong
	WANG Liyan
	et al

Cite this article:

LIU Jia,CUI Xuhong,WANG Liyan, et al. Effects of Premixed Insulin Combined with Metformin on Islet function Recovery in Newly Diagnosed Type 2 Diabetes Mellitus[J]. HeBei Med, 2019, 25(1): 18-21.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2019.01.005 OR http://www.hbyxzzs.cn/EN/Y2019/V25/I1/18

[1] Kang YM, Cho YK, Lee SE, et al. Cardiovascular diseases and life expectancy in adults with type 2 diabetes: a korean national sample cohort study[J].Clin Endocrinol Metab,2017,102(9):3443~3451.
[2] 戴筱君,高斯,施克新.地特胰岛素联合二甲双胍治疗2型糖尿病疗效观察[J].现代中西医结合杂志,2015,24(1):75~77.
[3] 杨彩娴,黄启亚,钟国权,等.新诊断2型糖尿病早期胰岛素强化治疗后三种治疗方案对胰岛β细胞功能及胰岛素抵抗的影响[J].中国糖尿病杂志,2016,8(10):613~617.
[4] 吴雁翔,许忆峰,单鸿,等.格列美脲联合预混胰岛素治疗2型糖尿病患者临床观察[J].辽宁中医药大学学报,2015,17(12):133~135.
[5] 梁峰,胡大一,沈珠军.2014美国糖尿病指南:糖尿病诊疗标准[J].中华临床医师杂志(电子版),2014,8(6):1182~1190.
[6] 陈亮,姚志灵,刘文浩.甘精胰岛素联合二甲双胍对老年2型糖尿病患者氧化应激的影响[J].重庆医学,2016,45(11):1502~1504.
[7] 翟丽敏,叶山东,顾俊菲,等.二甲双胍对2型糖尿病大鼠肾小球足细胞标志蛋白表达的影响[J].中华医学杂志,2015,95(40):3313~3316.
[8] 应文华,叶爱玲,叶韩镯.门冬胰岛素30联合二甲双胍治疗2型糖尿病观察[J].中国药师,2015,18(2):277~279.
[9] 叶景璐,钟兴,杜益君,等.艾塞那肽与预混胰岛素治疗新诊断2型糖尿病患者临床疗效和安全性比较[J].中国糖尿病杂志,2017,25(9):817~821.
[10] 张东铭,钱镭.低中比例预混胰岛素类似物在2型糖尿病患者治疗中的应用与选择[J].中华内分泌代谢杂志,2014,30(9):800~803.
[11] 孙毅宏,张永莉,石洁.甘精胰岛素联合二甲双胍治疗初发2型糖尿病的疗效观察[J].中国临床研究,2014,27(5):544~545.
[12] Kaneko S, Oura T, Matsui A, et al. Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diabetes[J]. Endocr, 2017,64(12):1165~1172
[13] 谢飞,郑卫华.地特胰岛素联合二甲双胍对2型糖尿病患者胰岛功能、胰岛素抵抗的影响[J].河北医药,2014,36(16):2487~2488.
[14] 徐芬娟,朱娟飞,沈中秋,等.预混胰岛素联合不同口服降糖药对2型糖尿病患者胰岛细胞功能及胰岛素敏感性的影响[J].浙江医学,2017,39(23):2121~2124.